News Trump 'already understands' need to incentivise R&D, says Me... Frazier takes swipe at price-hiking generics firms.
News Merrimack goes back to drawing board with $1bn Ipsen sell-of... Merrimack sells off Onivyde and generic cancer drug
News IBM Watson, Illumina collaborate on cancer genetics decision... IBM Watson for Genomics will inform cancer treatment decisions by analysing Illumina's genetic data.
News Owlstone seals further funding for cancer breathalyser Money will go towards commercial launch of its R&D services.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
